LIAISON® XL MUREX HIV AB / AG HT - COFEPRIS Registration 64R2019 SSA
Access comprehensive regulatory information for LIAISON® XL MUREX HIV AB / AG HT (LIAISON® XL MUREX HIV AB / AG HT) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 64R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on January 25, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO LIAISON® XL MUREX HIV AB / AG HT TIENE COMO OBJETIVO SER UTILIZADO COMO UNA AYUDA EN EL DIAGNÓSTICO DE LA INFECCIÓN POR VIH-1/VIH-2 Y COMO UNA PRUEBA DE DETECCIÓN PARA LAS DONACIONES DE SANGRE Y PLASMA. EL ENSAYO DEBE REALIZARSE EN INSTRUMENTOS
THE LIAISON® XL MUREX HIV AB/AG HT ASSAY AIMS TO BE USED AS AN AID IN THE DIAGNOSIS OF HIV-1/HIV-2 INFECTION AND AS A SCREENING TEST FOR BLOOD AND PLASMA DONATIONS. THE TEST MUST BE PERFORMED ON INSTRUMENTS